• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/61 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Patent holdings for IPC class C07D 233/61

Total number of patents in this class: 387

10-year publication summary

22
17
24
24
17
17
28
10
26
23
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
University of Pittsburgh - Of the Commonwealth System of Higher Education
3304
7
BIAL - Portela & CA, S.A.
214
6
PTC Therapeutics, Inc.
475
6
Bristol-myers Squibb Company
4742
5
Centre National de La Recherche Scientifique
11023
5
Agency for Science, Technology and Research
3733
5
Dana-Farber Cancer Institute, Inc.
2664
5
Institut Curie
615
5
Seren Technologies Limited
9
5
AstraZeneca AB
2814
4
Merck Patent GmbH
5728
4
Bayer Pharma AG
1014
4
President and Fellows of Harvard College
6094
4
Takeda Pharmaceutical Company Limited
2712
4
EA Pharma Co., Ltd.
96
4
Tetraphase Pharmaceuticals, Inc.
52
4
Toyama Chemical Co., Ltd.
88
4
The United States Government AS represented by The Department of Veterans Affairs
1329
4
Universite de Montpellier
1042
4
Nissan Chemical Corporation
2227
4
Other owners 294